INTRODUCTION
============

The vertebrate CNS is composed of a diverse range of morphologically and functionally distinct types of cells, and the correct functioning of the nervous system is critically dependent on the production of a sufficient and balanced number of each cell type. This cellular diversity arises from multipotent progenitor cells by complex developmental mechanisms, including cell proliferation, fate determination, differentiation, and survival. Identification of the molecules and mechanisms that generate the proper number of neuronal cell types is one of the major goals of developmental biology.

The retina has served as an excellent model system for studying the mechanisms of cell production in the vertebrate CNS. During development, progenitor cells in the presumptive neural retina give rise to six major classes of neurons and one glial cell class in an evolutionally conserved order, which follows a histogenetic sequence in the retina ([@B46]; [@B17]; [@B55]). The first cells that emerge from the retinal progenitor cells are retinal ganglion cells (RGCs), which are the sole output neurons in the retina and locate in the innermost layer (the ganglion cell layer \[GCL\]) of the mature retina ([@B45]). Whereas cell-intrinsic mechanisms play crucial roles in retinal cell diversification ([@B5]), several extrinsic signals derived from various sources in the eye influence RGC development ([@B19]; [@B2]), including fibroblast growth factors (FGFs; [@B35], [@B36]; [@B28]), Sonic hedgehog (Shh; [@B58]; [@B29]), vascular endothelial growth factor (VEGF; [@B16]), and Delta-Notch signaling ([@B4]). Considering the complexity of cellular and molecular interactions that mediate retinal development, however, it seems likely that additional extracellular signals are involved in regulation of RGC development.

Nel (neural epidermal growth factor \[EGF\]-like) is an extracellular glycoprotein that was initially identified in chickens ([@B30], [@B31]). In mammals, two related genes were subsequently identified and termed Nel-like 1 (Nell1) and 2 ([@B54]; [@B26]). Based on sequence similarities, Nell2 appeared to be the mammalian orthologue of chicken Nel. In this article, we refer to both Nel and Nell2 as Nel. The Nel/Nell proteins have significant structural similarities with thrombospondin-1, which plays important roles in a wide range of physiological and pathological conditions, such as tumor growth and metastasis, angiogenesis, wound healing, inflammation, and synaptogenesis ([@B1]). The Nel protein contains an N-terminal thrombospondin-1 domain, five chordin-like/von Willebrand factor C domains, and six EGF-like domains ([@B30], [@B31]). During development, Nel is expressed in many different regions of the developing nervous system, including the retina, cerebral cortex, hippocampus, amygdala, and spinal cord ([@B30]; [@B43]; [@B42], [@B41]). Previous studies showed that Nel stimulates differentiation of neuronal progenitor cells in the spinal cord and mitogenesis in dorsal root ganglia in chicks ([@B41]). In addition, we previously demonstrated that Nel inhibits outgrowth of RGC axons and induces growth cone collapse and axon retraction, and suggested that Nel acts as an inhibitory axon guidance molecule in establishment of the layer specificity in the visual projection ([@B23]; [@B40]). It was also shown that Nel promotes survival of cortical and hippocampal neurons in vitro ([@B3]) and of RGCs after optic nerve injury in vivo ([@B39]). In adults, targeted disruption of the Nel gene results in significant enhancement of long-term potentiation in the dentate gyrus ([@B33]). Moreover, Nel-deficient mice show impairment of spatial learning, further suggesting its functions in regulation of synaptic plasticity in the hippocampus ([@B34]). These results indicate that Nel plays crucial and diverse functions in the developing and adult nervous system. The cell surface receptor(s) for Nel remains to be identified.

In the developing retina, Nel is strongly expressed in RGCs ([@B42]). However, its functions in retinal development remain elusive. In this study, we investigate the functions of Nel in development of RGCs in the chick retina. Our results indicate that Nel positively regulates RGC production by both stimulating RGC differentiation and inhibiting programmed cell death.

RESULTS
=======

Nel is expressed in retinal pigment epithelium and RGCs in the developing chick eye
-----------------------------------------------------------------------------------

To explore potential functions of Nel in retinal development, we first examined its spatial and temporal expression patterns in the developing chick eye by RNA in situ hybridization. In chicks, invagination of the primary optic vesicle starts at Hamburger Hamilton stage (HH) 14 (embryonic day \[E\] 2.5), and the double-layered optic cup is formed at HH15 (E2.5). At those stages, Nel RNA expression was detected in the outer layer of the optic cup, the presumptive retinal pigment epithelium (RPE; [Figure 1A](#F1){ref-type="fig"}). At HH20 (E3.5), Nel expression in the RPE increased, and, in addition, significant expression of Nel RNA was detected in cells that occupy the inner surface of the central retina ([Figure 1B](#F1){ref-type="fig"}), where newly differentiated RGCs reside. Nel RNA expression in RGCs increased between E4 and E6 ([Figure 1C](#F1){ref-type="fig"}). Expression of Nel persisted and continued to be restricted to the RPE and RGCs at least until E18 ([Figure 1, C′, D, and D′](#F1){ref-type="fig"}). The observed strong expression of Nel in RGCs is consistent with previous reports ([@B42]; [@B53]).

![RNA and protein expression of Nel in the developing chick retina. (A--D) Nel expression detected by RNA in situ hybridization. Retinal sections prepared from different stages of chick embryos were hybridized with an RNA probe for Nel (violet). (A) HH14--15 (E2.5), (B) HH20 (E3.5), (C, C′) E6, and (D, D′) E18. RNA expression of Nel is initially restricted to the presumptive RPE (pe; A) but is also detected in RGCs (gc) at later stages (B--D). Nel RNA expression in the RPE and RGCs persists until at least E18 (D). In C and D, higher-magnification views of the RPE (areas indicated by small rectangles) are shown in insets (C′ and D′, respectively). In B and C, the sections are counterstained with methyl green (light blue). (E--G) Nel protein distribution detected by immunohistochemistry. Sections of HH17 (E3), E6 (F), or E18 (G) retina were treated with anti-Nel antibody (red). The Nel protein is mostly localized in the RPE and RGC layer. le, lens; nr, neural retina. Scale bars, 50 μm.](234fig1){#F1}

Because Nel is a secreted protein, it could in principle diffuse distances to be distributed in neighboring layers and tissues. We therefore examined the Nel protein distribution in the developing retina by immunohistochemistry using anti-Nel antibody ([@B23]). The distribution of the Nel protein showed a very similar pattern to that of Nel RNA expression ([Figure 1, E--G](#F1){ref-type="fig"}), indicating that most of the secreted Nel protein remains in the layers of its origin. This result is consistent with our previous observation that Nel RNA and protein show similar layer-specific distributions in the developing chick optic tectum ([@B23]). This limited diffusion of the Nel protein may be due to its heparin-binding activity ([@B26]; [@B40]), and the Nel protein may be trapped by heparin sulfate proteoglycans in situ soon after secretion from Nel-expressing cells.

Nel overexpression increases RGC number in vivo
-----------------------------------------------

The expression patterns of Nel in early retinal development raised the possibility that Nel may be involved in retinal neurogenesis, particularly in development of RGCs. To test this possibility directly in vivo, we constructed a replication-competent retroviral vector that drives bicistronic expression of Nel and an enhanced green fluorescent protein (EGFP) marker (RCAS-Nel-IRES-EGFP). As a negative control, we used the RCAS-IRES-EGFP vector, which expresses only EGFP. The expression vectors were transfected into the optic vesicle at HH9--11 (E1.5) by in ovo electroporation, and expression of the transgenes was assessed at later stages by fluorescence of EGFP and immunohistochemistry using anti-Nel antibody ([@B23]; [Figure 2, A--F](#F2){ref-type="fig"}).

![Nel overexpression results in increase in RGC number. (A--F) Overexpression of Nel by using RCAS-Nel-IRES-EGFP. The retrovirus construct was electroporated into the optic vesicle of HH9--11 (E1.5) chick embryos, and retinal sections were prepared at E5. An area of Nel overexpression (A--C) and a corresponding area transfected with the control RCAS-IRES-EGFP (D--F) are shown. Nel expression was detected by anti-Nel antibody (red), and transfection domains are marked by the EGFP reporter (green). (C, F) Merged images of the left two images. (A′, D') Higher-magnification views of the RPE (areas indicated by small rectangles in A and D, respectively). In Nel/EGFP transfection domains, ectopic expression of Nel in progenitor cells (pc) of the neural retina is detected. In addition, staining for the Nel protein in RGCs (gc) and RPE (pe) is stronger compared to that in control areas. (G--L) Effects of Nel overexpression on RGC production. Retinal sections were prepared at E8 from embryos transfected with RCAS-Nel-IRES-EGFP, and the production of RGCs was evaluated by immunohistochemistry for Brn3a (red). The transgene was introduced into half of the retina (overexpression \[OE\] side), which is marked by the EGFP reporter (green). (I) Merged image of G and H. (J, K) Higher-magnification views of Nel-overexpressing and corresponding untransfected areas in G (indicated by small rectangles), respectively. The number of Brn3a-positive cells significantly increased in Nel ectopic domains. on, optic nerve head. Scale bars, 50 μm. (L) Quantification of cell numbers in the GCL. The numbers of Brn3a-positive RGCs, syntaxin-positive displaced amacrine cells, and total cells in the GCL (4′,6-diamidino-2-phenylindole) in areas transfected with Nel and EGFP (Nel/EGFP) or EGFP only (EGFP) were compared with those in equivalent areas of the contralateral (untransfected) eye (Control) and indicated as mean ± SEM. \**p* \< 0.001, \*\**p* \< 0.0005. *n* = 6 embryos. ANOVA test.](234fig2){#F2}

To examine effects of Nel overexpression on RGC development, we incubated embryos transfected with the RCAS-Nel-IRES-EGFP vector until E8, when production of RGCs is mostly complete ([@B45]). Retinal sections were then prepared and stained for Brn3a, a specific marker for RGCs in the retina ([@B56]). Retinal neurogenesis occurs in a central-to-peripheral gradient ([@B50]; [@B35]) and also shows slight temporal-to-nasal and dorsal-to-ventral gradients ([@B45]). We therefore compared the numbers of Brn3a-positive cells between equivalent areas (e.g., central-temporal area) of transfected and untransfected (contralateral) retinas. We found that the number of Brn3a-positive cells increased by approximately 40% in regions transfected with RCAS-Nel-IRES-EGFP ([Figure 2, G--L](#F2){ref-type="fig"}). Transfection of the control vector that expresses only EGFP did not affect the production of Brn3a-positive cells in the retina ([Figure 2L](#F2){ref-type="fig"}).

During vertebrate retinal development, significant numbers of amacrine cells, which are mainly located in the superficial part of the inner nuclear layer (INL), migrate to the GCL. In chicks, those "displaced" amacrine cells are produced between E5.5 and E6.5 and comprise 20--35% of the total number of cells in the GCL ([@B12]; [@B8]; [@B27]). Therefore next we examined whether Nel overexpression affects the number of displaced amacrine cells by using the amacrine cell marker syntaxin. We found that in the retinal regions where Nel is overexpressed, the number of displaced amacrine cells in the GCL significantly decreases. The total cell numbers in the GCL showed a slight increase after Nel overexpression, although this difference was not statistically significant ([Figure 2L](#F2){ref-type="fig"}). These results indicate that Nel overexpression promotes the genesis of RGCs and decreases the number of displaced amacrine cells in the GCL.

Decrease of RGC number by RNA interference knockdown of Nel
-----------------------------------------------------------

Next we examined whether Nel is essential for the production of the proper number of RGCs in vivo. To test this, we designed artificial microRNAs (miRNAs) to target Nel expression and introduced them into the developing eye by in ovo electroporation. Because RGC production continues over at least 5--6 d, it was necessary that the production of the artificial miRNA be maintained throughout the period of RGC generation without significant reduction in expression. To achieve stable expression of transgenes, we used a transposon-mediated gene transfer system ([@B49]) that uses the Tol2 transposable element ([@B25]). We made a Tol2 transposon construct (pT2K-CAGGS-Nel miRNA482/2461-emerald GFP \[EmGFP\]) that expresses Nel-specific miRNA and an EmGFP marker under the CAGGS promoter. As a negative control, we used a transposon vector carrying nonspecific miRNA sequences with the EmGFP marker gene (pT2K-CAGGS-Control miRNA-EmGFP). When introduced into cells with a transposase activity, the expression cassette would be excised from the plasmid and integrated into the host genome, allowing stable expression of the miRNA and the EmGFP marker ([Figure 3A](#F3){ref-type="fig"}). We electroporated the transposon vector of Nel miRNA with the transposase expression vector pCAGGS-T2TP into the optic vesicle at HH9--11 (E1.5). Electroporation efficiency was monitored by expression of EmGFP, and effects of RNA interference (RNAi) on Nel expression was evaluated by immunohistochemistry using anti-Nel antibody. At E4.5, endogenous expression of Nel was found to be significantly reduced in EmGFP-expressing cells in the RPE ([Figure 3, B--D](#F3){ref-type="fig"}). At E8, reduction of Nel expression was also obvious in RGCs ([Figure 3, E--I](#F3){ref-type="fig"}).

![Knockdown of Nel expression by transposon-mediated transfer of artificial miRNA. (A) A scheme showing transposition of a Tol2-flanked expression cassette for artificial Nel miRNA and EmGFP by transposase. When a Tol2 transposon construct (pT2K-CAGGS-Nel miRNA482/2461-EmGFP) is introduced into cells with a transposase expression construct (pCAGGS-T2TP), the Tol2-flanked cassette is excised from the vector and integrated into the host genome by the transposase activity (modified from [@B49]). (B--I) RNAi knockdown of Nel expression in the developing eye. A transposon construct containing an expression cassette of Nel miRNA and EmGFP was cotransfected with a transposase expression vector into the optic vesicle by in ovo electroporation at HH9--11 (E1.5). Retinal sections were prepared at E4.5 (B--D) or E8 (E--I), and expression of Nel was examined by immunohistochemistry using anti-Nel antibody (red). Half of the retina was transfected with the transposon constructs and marked by EmGFP (knockdown \[KD\] side, green). The boundary between transfected and untransfected (Control) sides is indicated by a dotted line in C and F. (D, G) Merged images of the left two images. (B--D) At E4.5, Nel expression is significantly reduced in the RPE (pe) cells that express EmGFP. Note the complementary pattern of Nel immunostaining and EmGFP expression. (E--I) At E8, Nel expression in the RPE and RGCs (gc) is decreased on the knockdown side (left side of the section). (H, I) Higher-magnification views of knockdown and corresponding untransfected areas in E (indicated by small rectangles), respectively. Scale bars, 50 μm. nr, neural retina; of, optic fissure.](234fig3){#F3}

Then we examined whether RNAi knockdown of Nel affects the numbers of RGCs and displaced amacrine cells. Whereas transfection of the control vector did not cause any changes in the RGC or displaced amacrine cell numbers, introduction of the Nel miRNA construct with the transposase expression vector resulted in an approximately 40% reduction in the number of Brn3a-positive cells and to a lesser extent, an increase in the number of displaced amacrine cells ([Figure 4](#F4){ref-type="fig"}). Taken together, these results indicate that Nel regulates the number of RGCs positively and that of displaced amacrine cells negatively and is essential for the generation of the proper numbers of retinal neurons during development.

![Reduction of the RGC number by RNAi knockdown of Nel expression. A transposon construct of artificial Nel miRNA and EmGFP (pT2K-CAGGS-Nel miRNA482/2461-EmGFP) was cotransfected with a transposase expression vector (pCAGGS-T2TP) into the optic vesicle by in ovo electroporation at HH9--11 (E1.5). Retinal sections were prepared at E8 and stained for Brn3a (red). (A--C) Representative section through the optic nerve head (on). The transgenes were introduced into half (knockdown \[KD\] side, green) of the retina. Compared to the control side, the number of Brn3a-positive cells is significantly reduced on the knockdown side. (D, E) Higher-magnification views of RNAi knockdown (D) and corresponding untransfected (E) areas in A (indicated by small rectangles). Scale bars, 50 μm. (F) Quantification of cell numbers in the GCL. The numbers of Brn3a-positive RGCs, syntaxin-positive displaced amacrine cells, and total cells in the GCL (4′,6-diamidino-2-phenylindole) in areas transfected with Nel miRNA or control miRNA were compared with those in equivalent areas in the contralateral (untransfected) eye (Control) and plotted as mean ± SEM. \**p* \< 0.05, \*\**p* \< 0.0005. *n* = 6 embryos. ANOVA test.](234fig4){#F4}

Effects of Nel on other types of retinal cells
----------------------------------------------

Next we tested whether Nel overexpression or knockdown affects the production of other types of retinal cells. To this end, we examined the numbers of different types of retinal cells at E18 by using AP2α as a bipolar cell marker, Pax6 as a horizontal cell marker, rhodopsin as a marker for rods, visinin as a marker for cones, and vimentin as a Müller glia marker. As shown in [Figure 5](#F5){ref-type="fig"}, neither overexpression nor RNAi knockdown caused significant changes in the numbers of those retinal cells. In addition, the amacrine cell numbers in the INL were not significantly altered by the modulations of Nel expression levels. These results indicate that the effects of Nel expression are confined to the GCL of the retina.

![Effects of Nel on production of different retinal cell types. Expression constructs for Nel cDNA (A) or artificial miRNA (B) were transfected into the optic vesicle by in ovo electroporation at HH9--11 (E1.5). The numbers of different types of retinal cells in transfected areas were compared with those in corresponding areas transfected with control vectors (EGFP in A, control RNAi in B) at E18. No significant differences were detected in the numbers of AP2α-positive bipolar cells, Pax6-positive horizontal cells, rhodopsin-positive rods, visinin-positive cones, or vimentin-positive Müller glia. In addition, the amacrine cell numbers in the INL were not significantly altered. *n* = 6 embryos. ANOVA test.](234fig5){#F5}

Nel does not significantly affect proliferation of retinal progenitor cells
---------------------------------------------------------------------------

The potential mechanisms by which Nel positively regulates RGC production include stimulation of retinal progenitor proliferation, promotion of RGC differentiation, and inhibition of apoptosis. First, we tested whether Nel can enhance proliferation of progenitor cells in the developing retina. We electroporated RCAS-Nel-IRES-EGFP into the optic vesicle at HH9--11 (E1.5) and counted the number of bromodeoxyuridine (BrdU)-positive cells after 3 h of in vivo labeling at E6. No significant difference in the number of BrdU-positive cells was observed between Nel-overexpressing and control areas ([Figure 6, A, B, and I](#F6){ref-type="fig"}). In addition, RNAi knockdown of Nel expression did not affect the number of BrdU-positive cells ([Figure 6, C, D, and J](#F6){ref-type="fig"}). In a separate set of experiments, retinal sections were examined by immunohistochemistry using anti--phosphohistone H3 (PH3) antibody. Neither overexpression nor RNAi knockdown of Nel caused any significant change in the number of PH3-positive cells ([Figure 6, E--J](#F6){ref-type="fig"}). These results suggest that Nel does not serve as a mitogen during early retinal development.

![Effects of Nel on proliferation of retinal progenitor cells. Expression constructs for Nel cDNA (A, E) or artificial miRNA (C, G) were transfected into the optic vesicle by in ovo electroporation at HH9--11 (E1.5), and effects on cell proliferation were examined by comparing with corresponding areas transfected with control vectors (EGFP in B, F, I; control RNAi in D, H, J). Areas in the central retina are shown. (A--D) Embryos were labeled with BrdU in ovo for 3 h at E6, and retinal sections were prepared and stained with anti-BrdU antibody. (E--H) Retinal sections of E4.5 chicks were stained for PH3. Scale bars, 50 μm. nr, neural retina; pe, pigment epithelium. (I, J) Quantifications of BrdU- and PH3-positive cells. The numbers of stained cells are shown as percentage control in mean ± SEM. No significant differences were detected between Nel overexpression, RNAi knockdown, and their controls. *n* = 6 embryos. ANOVA test.](234fig6){#F6}

Nel accelerates the progression of RGC differentiation wave
-----------------------------------------------------------

Next we examined the effects of Nel on RGC differentiation. During development, RGC differentiation occurs in a central-to-peripheral gradient, such that RGCs are initially produced in the central retina and then the wave of differentiation proceeds from the central to peripheral retina, much like an expanding circle ([@B50]; [@B35]). In addition, it was reported that neurogenesis in the chick retina shows slight temporal-to-nasal and dorsal-to-ventral gradients ([@B45]). To test whether Nel affects the progression of the RGC differentiation wave, we overexpressed Nel in half (nasal or temporal) of the retina at HH9--11 (E1.5), and examined the progression of RGC differentiation by immunohistochemistry for the RGC marker Islet-1 ([@B4]) at E4.5, when RGCs are still actively produced. Equal numbers of nasally and temporally transfected retinas were examined. We found that the overexpressing side of the retina contained significantly larger numbers of Islet-1--positive cells than the control side ([Figure 7, A, B, and E](#F7){ref-type="fig"}). Furthermore, compared to the control side, the peripheral edge or front of RGC differentiation reached farther from the central toward peripheral retina ([Figure 7, A, B, and F](#F7){ref-type="fig"}), indicating that Nel overexpression accelerates the movement of the RGC differentiation wave. Conversely, when expression of Nel was knocked down by RNAi in half of the retina, the knockdown side of the retina not only contained fewer Islet-1--positive cells, but also showed slower progression of the RGC differentiation wave ([Figure 7, C--F](#F7){ref-type="fig"}). These results indicate that Nel enhances the rate of RGC differentiation and its progression from the central to peripheral retina.

![Enhancement of the progression of RGC differentiation wave by Nel. (A--D) Nel was either overexpressed (A, B) or knocked down (C, D) in half (left side) of the developing retina by in ovo electroporation at HH9--11 (E1.5). Retinal sections were prepared at E4.5, and RGCs were detected by immunohistochemistry using anti--Islet-1 antibody (red). The areas of transgene expression are marked by expression of a GFP reporter (transfection side, green). Compared to the control side, Nel overexpression increased the number of RGCs and accelerated the progression of RGC differentiation wave. Conversely, RNAi knockdown of Nel decreased the RGC number and slowed down the rate of their differentiation. The white lines indicate the midline of the retina, and the arrows show the peripheral edge of RGC differentiation wave. le, lens. (E) Quantification of RGC numbers. The number of Islet-1--positive cells is shown as percentage control in mean ± SEM. (F) Quantification of progression of the RGC differentiation wave. The angles subtended by the arcs of RGC cells were measured on the transfection (θt) and control sides (θc), as indicated. Effects on wave progression were quantified as θt/θc × 100 and plotted as mean ± SEM. Equal numbers of nasally and temporally transfected retinas were examined. \**p* \< 0.005, \*\**p* \< 0.001. *n* = 6 embryos each for temporal and nasal transfection. Paired Student\'s *t* test.](234fig7){#F7}

Nel protects retinal cells from developmental cell death
--------------------------------------------------------

In retinal development, the period of RGC production partly overlaps with the earlier peak phase of developmental cell death ([@B11]). Therefore next we examined whether manipulations of Nel expression levels affect programmed cell death during retinal development. Consistent with previous reports ([@B58], [@B59]), only a few apoptotic cells were detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay in central regions of the normal E6 retina. Overexpression of Nel resulted in a decrease in the number of TUNEL-positive cells in transfected areas ([Figure 8, A, B, and E](#F8){ref-type="fig"}). Conversely, when Nel expression was knocked down by RNAi, a marked increase in the number of TUNEL-positive cells was observed ([Figure 8, C--E](#F8){ref-type="fig"}). Transfection of control vectors did not change the number of TUNEL-positive cells (Supplemental Figure S1). These results indicate that Nel acts to protect RGCs from programmed cell death during retinal development.

![Nel promotes survival of retinal cells during development. (A--D) Nel was either overexpressed (A, B) or knocked down (C, D) in half (left side) of the developing retina by in ovo electroporation at HH9--11 (E1.5). Retinal sections were prepared at E6, and apoptotic cells were detected by TUNEL assay (red). The areas of transgene expression are marked by expression of a GFP reporter (transfection side, green). A subset of TUNEL-positive cells is indicated by arrows. Compared to the control side, Nel overexpression decreased the number of TUNEL-positive cells, whereas RNAi knockdown of Nel drastically increased it. nr, neural retina; on, optic nerve. Scale bars, 100 μm. (E) Quantification of apoptotic cells. The number of TUNEL-positive cells on the transfected side was compared with that on the control side and plotted as mean ± SEM. \**p* \< 0.05, \*\**p* \< 0.0005. *n* = 6 embryos. ANOVA test.](234fig8){#F8}

DISCUSSION
==========

Functions of Nel in RGC development
-----------------------------------

Several lines of evidence obtained in this study indicate that Nel positively regulates the production of RGCs during development. First, Nel is strongly expressed in RGCs ([@B42]; [@B53]) and the RPE in the developing eye. Second, gain-of-function studies show that retroviral overexpression of Nel in the developing retina increases RGC number. Third, loss-of-function experiments using RNAi knockdown demonstrate that reduction of Nel expression levels results in decreased number of RGCs. We also showed that alterations of Nel expression levels do not exert obvious effects on cell proliferation but significantly affect the rate of RGC differentiation and developmental cell death, suggesting that Nel enhances the production of RGCs by promoting their differentiation and survival.

During retinal development, RGC differentiation initially occurs in the central retina, and the wave of differentiation proceeds toward the periphery of retina. Our results show that overexpression of Nel accelerates the progression of the RGC differentiation wave, whereas RNAi knockdown of Nel expression retards the movement of the wave front. This effect of Nel appears similar to that previously reported for FGF signaling. During the initial stage of chick retinogenesis, FGF1 is expressed at high levels in the peripheral part of the developing retina ([@B7]). In a retinal explant culture system, FGF1 promotes the progression of RGC differentiation wave, and inhibition of the FGF receptor signaling inhibits the movement of the wave front ([@B35]). In *Xenopus* embryos, overexpression of FGF2 in retinal progenitor cells results in a 35% increase of RGCs without affecting retinal cell proliferation ([@B44]). Whereas both Nel and FGF1 accelerate the progression of RGC differentiation wave, the central-to-peripheral gradient of RGC differentiation is preserved in the presence of excess Nel or FGF1. Given that the cells at the wave front are more mature than those in the peripheral retina, these results may suggest that Nel and FGF1 act to stimulate further differentiation of nascent RGCs in final stages of RGC development ([@B22]).

Programmed cell death plays crucial roles in regulation of cell numbers during neural development, and a significant portion of newly generated RGCs undergo programmed cell death during development. The present study shows that whereas Nel overexpression decreases number of apoptotic cells in the developing retina, RNAi knockdown of Nel dramatically increases it. These results suggest that in addition to acceleration of RGC differentiation, suppression of developmental cell death contributes to promotion of RGC production by Nel. Importance of developmental cell death in regulation of RGC numbers has also been shown by studies on brain-derived neurotrophic factor (BDNF). Application of BDNF to chick embryos in ovo significantly inhibits the earlier peak phase of developmental cell death in the retina and results in a 60--90% increase in RGC number ([@B11]). Nel was shown to promote survival of cortical and hippocampal neurons in primary culture ([@B3]). More recently, it was reported that overexpression of Nel in the retina promotes RGC survival in vivo after optic nerve transection ([@B39]). These results indicate that Nel can act as a survival factor for multiple types of neurons.

We found that the number of displaced amacrine cells in the GCL is negatively affected by Nel expression. Given that amacrine cells are among the early-born neurons in the retina and are generated at approximately the same time as RGCs ([@B6]), Nel may act to cause a cell fate shift from amacrine cells to RGCs, although the change in amacrine cell number is restricted in the GCL, and no significant effects were observed on amacrine cell number in the INL by Nel overexpression or RNAi knockdown. Alternatively, the displacement of amacrine cells in the GCL may be negatively controlled by the number of RGCs in the layer, and thus the observed effects on the number of displaced amacrine cells may represent secondary effects due to the change of RGC number caused by modulation of Nel expression.

Nel in molecular interaction network during retinal development
---------------------------------------------------------------

During retinal development, Nel is produced by two different sources in the eye ([Figure 9](#F9){ref-type="fig"}). First, at early stages of retinal development before the first RGCs emerge in the GCL, the presumptive RPE acts as the sole source of Nel in the developing eye. Throughout eye development, the neural retina and the RPE are kept in close apposition, and development of the two tissues occurs in concert ([@B52]). Ablation of the RPE severely disrupts development of the neural retina ([@B51]; [@B48]). Interestingly, compared to pigmented wild-type mice, more RGCs are produced during the initial period of retinal neurogenesis in albino mice, which lack pigmentation in the RPE. Furthermore, pharmacological inhibition of pigment production increases the number of RGCs in eyecups isolated from pigmented mice ([@B47]). A variety of growth factors are secreted from the RPE, including VEGF, FGF, and pigment epithelium--derived factor (PEDF; [@B52]). In *Xenopus*, PEDF supports normal development of photoreceptor neurons and Müller cells after removal of the RPE, demonstrating that RPE-derived PEDF plays important roles in the final stages of retinal development ([@B20], [@B21]). Although the Nel protein appears to localize mostly in the presumptive RPE at this stage, our results raise the possibility that RPE-derived Nel functions as a part of the molecular network between the RPE and neural retina and acts to increase, directly or indirectly, RGC production in early stages of retinal neurogenesis.

![Expression and potential modes of actions of Nel in retinal neurogenesis. (A) During retinal development, Nel is secreted from two different types of cells. Left, at early stages of retinal neurogenesis before RGCs are produced, Nel is expressed exclusively in the presumptive retinal pigment epithelium. Right, at later stages, newly differentiated RGCs also secrete Nel, whereas Nel expression in the RPE is maintained. (B) Nel accelerates the rate of differentiation of retinal progenitor cells into RGCs and inhibits apoptosis of retinal cells. Sources of Nel are indicated in red. nr, neural retina; pe, retinal pigment epithelium; rgc, retinal ganglion cells; rp, retinal progenitor cells.](234fig9){#F9}

Second, strong Nel expression was detected in RGCs that had migrated into the GCL. Previous studies showed that differentiated RGCs secrete several factors that affect RGC production. For example, Shh is produced by newly differentiated RGCs and required for the propagation of the neurogenic wave toward the peripheral retina ([@B29]). Shh also suppresses the generation of additional RGCs behind the neurogenic wave front ([@B58]). In addition, VEGF produced by differentiated RGCs increases proliferation of retinal progenitors and decreases production of RGCs ([@B16]). The present study suggests that Nel is a novel RGC-derived factor that positively regulates RGC production.

The relative contributions and respective functions of RPE- and RGC-derived Nel in RGC production remain elusive. In addition, it is not clear whether RPE-derived Nel affects expression of RGC-derived Nel, or expressions of RPE- and RGC-derived Nel are independently regulated. We plan to address those issues in future studies by creating and analyzing conditional (RPE- and RGC-specific) knockout mice of Nel.

Gene silencing in chick embryos by transposon-mediated integration of artificial miRNA transgenes
-------------------------------------------------------------------------------------------------

Although chick embryos have long been used as a favorite model organism in the field of developmental biology, robust and efficient loss-of-function approaches had not been available for the chick until recently. In the past decade, RNAi has been successfully used in chick embryos by electroporating small interfering RNAs (siRNAs; [@B18]) or expression vectors for short hairpin RNA ([@B24]) in ovo. More recently, an RCAS retrovirus-based siRNA delivery system was shown to efficiently knock down gene expression in chick embryos ([@B15]).

In loss-of-function analysis of this study, we introduced artificial miRNA transgenes into the developing chick retina by using a transposon-mediated gene transfer system ([@B49]). This method offers several distinct advantages. First, it supports stable expression of the transgene and thus persistent production of miRNA. Electroporation of conventional expression vectors permits only transient expression of the transgene, usually lasting only for several days in embryonic cells, because of the inability of the electroporated plasmid to be integrated into chromosomes. In contrast, the present method involves chromosomal integration of the expression cassette by activity of coelectroporated transposase and therefore can achieve stable expression of the transgenes. Second, the cells that express the transgene can be easily traced because each of the transfected cells is clearly marked by the EmGFP marker. Third, because expression of miRNA and EmGFP is driven by the same CAGGS promoter, the risk of promoter interference is avoided, which is one of the common problems with retroviral vectors containing an additional promoter to attain dual gene expression (e.g., [@B57])). Finally, the areas of transfection can be controlled by properly choosing the type and positions of electrodes. Because this method does not use replication-competent retroviral vectors, there is no transmission of the transgene to neighboring cells after the electroporation. Within the transfected retinas, areas that do not express the transgene serve as a good internal control. Therefore this system provides a stable and efficient loss-of-function option and can contribute to the analysis of gene functions during chick development.

Diverse functions of Nel in visual system development
-----------------------------------------------------

In the chick visual system, Nel is expressed not only in RGCs (projecting neurons), but also in the optic tectum (the main target of RGC axons in nonmammalian vertebrates). Nel expression in the chick tectum is detected as early as E5. Expression levels of Nel significantly increase between E8 and E12, and the high expression is maintained at least until E18. First RGC axons reach the tectum by E6, and RGC axons project to the specific layers ("retinorecipient laminae") in the superficial part of the tectum between E12 and E18. During this period, Nel expression in the tectum is confined to deeper layers of the tectum, which RGC axons do not normally innervate ("nonretinorecipient laminae"). Because Nel inhibits outgrowth of RGC axons and induces growth cone collapse and axon retraction in vitro, these results suggest that Nel may act as an inhibitory axon guidance cue that prevents RGC axons from invading inappropriate layers in the deeper part of the tectum and thus contribute to the establishment of the layer specificity in the visual projection ([@B23]; [@B40]). In addition, in view of the functions of Nel in RGC production revealed in this study, it seems plausible that Nel could also have roles in differentiation and survival of tectal neurons in nonretinorecipient laminae.

It is intriguing that Nel exerts both positive (promotion of differentiation and survival) and negative (inhibitory effects on axons) effects on RGCs. Several other axon guidance molecules were also reported to exert both positive and negative effects on neurons. Such examples include ephrins, Wnt ([@B10]), and netrins ([@B38]). Because the Nel protein consists of different domains, it seems likely that different domains interact with distinct receptors and exert different functions, as is the case for thrombospondin-1 ([@B1]). Interestingly, Nel exerts neuroprotective effects on cultured neurons at concentrations lower than those required for inhibitory effects on RGC axons ([@B3]). This may suggest that Nel exerts inhibitory axon guidance functions and neuroprotective effects through distinct receptors that have different affinities for the ligand. Alternatively, the same receptor(s) may mediate both positive and negative signals in response to different concentrations of the ligand, as shown for Eph receptor--ephrin interactions ([@B13]; [@B32]). Further studies, including identification of its receptors, would be required to fully understand the molecular mechanisms of Nel functions. Nonetheless, it has become increasingly apparent that Nel is a multifunctional molecule that plays crucial roles in development of the vertebrate nervous system and its functions.

MATERIALS AND METHODS
=====================

Chick embryos
-------------

Fertilized White Leghorn chicken eggs were purchased from Henry Stewart (Louth, United Kingdom) and incubated at 38°C until use.

In situ RNA hybridization
-------------------------

In situ RNA hybridization was performed using digoxigenin-labeled probes for Nel as previously described ([@B23]), using 12- to 30-μm frozen sections of the embryonic retina.

Plasmid constructs
------------------

For construction of the RCAS-IRES-EGFP plasmid, cDNA sequences containing IRES-EGFP (nucleotide numbers 666--1973) of the pIRES2-EGFP vector (Clontech, Mountain View, CA) were amplified by PCR. Both the 5′ and 3′ PCR primers contain an artificial *Cla*I site, and the 3′ *Cla*I site was protected by a 5′ guanine, thus preventing *Cla*I cleavage when methylated, as previously described ([@B37]). The PCR product was cloned into the *Cla*I site of the replication-competent avian retroviral vector RCAS ([@B9]). The RCAS-Nel-IRES-EGFP vector was constructed by inserting the protein-coding region of Nel cDNA (GenBank accession number NM_001030740.1, nucleotide numbers 118--2565) into the RCAS-IRES-EGFP vector upstream of the IRES at the functional *Cla*I site.

For RNAi knockdown, we designed pairs of single-stranded DNA oligonucleotides (one encoding target pre-miRNA and the other corresponding its complement) for 10 potential target sequences by using RNAi Designer (Invitrogen, Carlsbad, CA; <https://rnaidesigner.invitrogen.com/rnaiexpress/>). After annealing, the double-stranded oligonucleotides were individually cloned into the pcDNA6.2-GW/EmGFP-miRNA vector (Invitrogen). Knockdown effects of each construct were evaluated by cotransfection with a Nel-AP expression vector into HEK293T cells, followed by measurement of AP activity in the culture media. The two most potent target sequences were selected (corresponding to nucleotide numbers 482--502 and 2461--2481, respectively) and tandemly cloned into the pcDNA6.2-GW/EmGFP-miRNA vector (pcDNA6.2-GW--Nel miRNA482/2461-EmGFP) according to the manufacturer\'s instructions. To construct the pT2K-CAGGS-Nel miRNA482/2461-EmGFP vector, cDNA sequences encoding the two pre-miRNA and EmGFP of the pcDNA6.2-GW/Nel miRNA 482/2461-EmGFP vector were amplified by PCR with an artificial *Eco*RI site on both ends (5′-GGGAATTCTCTGGCTAACTAGAGAAC-3′ and 5′-CCG­AATTCCCTCTAGATCAACCACT-3′) and cloned into the pT2K-CAGGS vector. The control pT2K-CAGGS-Control miRNA-EmGFP vector was constructed by cloning the corresponding region of the pcDNA6.2-GW/EmGFP-miRNA negative control plasmid (Invitrogen) into the pT2K-CAGGS vector using the same set of PCR primers and restriction enzyme sites as mentioned. The pT2K-CAGGS and pCAGGS-T2TP vectors were kindly provided by Yoshiko Takahashi (Kyoto University, Kyoto, Japan) and Koichi Kawakami (National Institute of Genetics, Mishima, Japan), respectively.

In ovo electroporation
----------------------

In ovo electroporation was performed as described previously ([@B14]). Briefly, a small amount of plasmid DNA solution (5 μg/μl each) mixed with fast green (dye tracer) was injected into the lumen of the optic vesicle of HH9--11 (E1.5) chick embryos in windowed eggs. Parallel platinum-coated electrodes spaced at 3 mm were placed perpendicular to the long axis of the embryo, one electrode being on the anterior (nasal) side and the other electrode on the posterior (temporal) side of the optic vesicle. Five square pulses (25 V, 50 ms/s) were applied by a CUY21 electroporator (Nepa Gene, Ichikawa, Japan). The levels of ectopic expression varied in different embryos. Only the embryos that showed significant levels of expression were used for analysis. Equal numbers of nasally and temporally transfected retinas were analyzed.

Immunohistochemistry and TUNEL assay
------------------------------------

For immunohistochemistry, embryonic retinas were fixed with 4% paraformaldehyde, cryoprotected with 30% sucrose in phosphate-buffered saline (PBS), embedded in OCT compound, frozen, and sectioned at 12--30 μm. Immunohistochemistry for Nel protein was performed as described previously ([@B23]), except that Alexa Fluor 594--conjugated anti-rabbit immunoglobulin G (IgG; 1:1000; Invitrogen) was used as secondary antibody. For immuno­staining of Brn3a, Islet-1, PH3, Pax6, and AP2α, sections were processed for antigen retrieval in a citrate buffer solution (10 mM trisodium citrate, 0.05% Tween-20) at 95°C for 3 min, blocked in a blocking solution (10% donkey serum, 0.3% Triton X-100 in PBS) for 1 h at room temperature, and treated with primary and secondary antibodies in an antibody dilution solution (0.3% Triton X-100, 1% bovine serum albumin in PBS). The following antibodies were used: anti-Brn3a (1:100, clone 5A3.2; Millipore, Billerica, MA), anti--Islet-1 (1:50, clone 39.4D5; Developmental Studies Hybridoma Bank \[DSHB\], University of Iowa, Iowa City, IA), anti-PH3 (1:100; Millipore), anti-syntaxin (1:2000; Sigma-Aldrich, St. Louis, MO), anti-Pax6 (1:200; DSHB), anti-PKCα (1:2000; Sigma-Aldrich), anti-vimentin (1:2000; DSHB), anti-rhodopsin (1:200; Sigma-Aldrich), anti-visinin (1:100; DSHB); anti--AP2-α (1:200; DSHB), Alexa Fluor 594--conjugated anti-mouse IgG (1:1,000; Invitrogen), and Alexa Fluor 488--conjugated anti-rabbit IgG (1:400; Invitrogen). The TUNEL assay was performed by using the In Situ Cell Death Detection Kit, TMR red (Roche Applied Science, Indianapolis, IN), according to the manufacturer\'s instructions. For quantification, the number of positive cells in transfected retinal regions was scored in a high-power optic field and compared with that in equivalent regions of the contralateral (untransfected) retinas or corresponding control areas. At least three fields were examined for each retina, and at least six retinas were analyzed for each type of treatment. Equal numbers of nasally and temporally transfected retinas were analyzed.

Statistical analyses
--------------------

Statistical significance of the data was determined using analysis of variance (ANOVA) or Student\'s *t* test.
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